Klow vs OTR-AC — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Klow is a vendor peptide blend combining TB-500, BPC-157, KPV, and GHK-Cu - four compounds covering systemic tissue repair, angiogenesis, gut protection, anti-inflammation, and skin regeneration. It is the expanded version of Tri-Heal (TB-500 + BPC-157 + KPV), with GHK-Cu added f...
Calculate Klow dose →OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneously to compensate for GI degradation and first-pass metabolism. The oral route p...
Calculate OTR-AC dose →| Parameter | Klow | OTR-AC |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Vendor Blend | Preclinical |
| Half-Life | - | 4–6 hours (estimated, oral) |
| Typical Dose | - | 2–5 mg |
| Frequency | - | Once daily |
| Route | Subcutaneous | Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.